Inventor · disambiguated record
Kevin N. Sill
Also filed as: SILL KEVIN · SILL KEVIN N
49 granted patents·30 pending applications·483 citations·filing 2005–2024
98Inventor score
Files withINTEZYNE TECHNOLOGIES INC23BREITENKAMP KURT8SILL KEVIN N8INTEZYNE TECH INC6MIROSEVICH JANNI6
Top patents by PatentIndex Score
79 records- 0198US7560588B2Poly(ethylene glycol) containing chemically disparate endgroupsINTEZYNE TECHNOLOGIES INC·Filed 2007·Granted Jul 14, 2009·39 cites·22 claims
- 0297US8263665B2Polymeric micelles for drug deliverySILL KEVIN N·Filed 2009·Granted Sep 11, 2012·66 cites·14 claims
- 0397US7638558B2Polymeric micelles for drug deliveryINTEZYNE TECHNOLOGIES INC·Filed 2006·Granted Dec 29, 2009·80 cites·14 claims
- 0496US8980326B2Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agentsSILL KEVIN N·Filed 2010·Granted Mar 17, 2015·14 cites·5 claims
- 0596US7799339B2Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agentsINTEZYNE TECHNOLOGIES INC·Filed 2008·Granted Sep 21, 2010·15 cites·1 claims
- 0695US11040993B2Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereofBOLD THERAPEUTICS INC·Filed 2020·Granted Jun 22, 2021·4 cites·31 claims
- 0795US10836869B1Polymer excipients for drug delivery applicationsTYNDALL FORMULATION SERVICES LLC·Filed 2020·Granted Nov 17, 2020·13 cites·3 claims
- 0895US7601796B2Synthesis of hybrid block copolymers and uses thereofINTEZYNE TECHNOLOGIES INC·Filed 2006·Granted Oct 13, 2009·23 cites·10 claims
- 0995US7589240B2Quantum dots tailored with electronically-active polymersUNIV MASSACHUSETTS·Filed 2005·Granted Sep 15, 2009·12 cites·8 claims
- 1094US11718754B2Poly(sarcosine) polymer excipientsCALUSA BIO LLC·Filed 2022·Granted Aug 8, 2023·2 cites·24 claims
- 1194US11692099B2Poly(sarcosine) polymer excipientsCALUSA BIO LLC·Filed 2022·Granted Jul 4, 2023·2 cites·20 claims
- 1294US8287910B2Polymeric micelles for polynucleotide encapsulationMIROSEVICH JANNI·Filed 2010·Granted Oct 16, 2012·47 cites·9 claims
- 1394US7618944B2Encapsulated amyloid-beta peptidesINTEZYNE TECHNOLOGIES INC·Filed 2008·Granted Nov 17, 2009·34 cites·10 claims
- 1493US11739111B2Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereofBOLD THERAPEUTICS INC·Filed 2021·Granted Aug 29, 2023·2 cites·8 claims
- 1593US10918619B1Formulations of paclitaxel with poly(amino acid) block polymersTYNDALL FORMULATION SERVICES LLC·Filed 2020·Granted Feb 16, 2021·4 cites·7 claims
- 1693US10611787B2Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereofBOLD THERAPEUTICS INC·Filed 2018·Granted Apr 7, 2020·4 cites·7 claims
- 1791US11286344B2Polymer excipients for drug delivery applicationsTYNDALL FORMULATION SERVICES LLC·Filed 2020·Granted Mar 29, 2022·2 cites·15 claims
- 1891US9078930B2Block copolymers for stable micellesINTEZYNE TECHNOLOGIES INC·Filed 2013·Granted Jul 14, 2015·15 cites·14 claims
- 1990US8299128B2Compositions comprising polymeric micelles for drug deliverySILL KEVIN N·Filed 2010·Granted Oct 30, 2012·12 cites·23 claims
- 2090US8263663B2Azide functionalized peptide targeting groupsSILL KEVIN N·Filed 2010·Granted Sep 11, 2012·10 cites·1 claims
- 2189US8779008B2Polymeric micelles for drug deliveryINTEZYNE TECHNOLOGIES INC·Filed 2012·Granted Jul 15, 2014·9 cites·1 claims
- 2289US8426477B1Polymeric micelles for drug deliveryBREITENKAMP KURT·Filed 2012·Granted Apr 23, 2013·11 cites·1 claims
- 2389US8268936B2Synthesis of hybrid block copolymers and uses thereofBREITENKAMP KURT·Filed 2009·Granted Sep 18, 2012·8 cites·14 claims
- 2488US9499665B2Block copolymers for stable micellesINTEZYNE TECH INC·Filed 2015·Granted Nov 22, 2016·6 cites·1 claims
- 2588US8609146B2Multi-block copolymers for the preparation of stabilized micellesINTEZYNE INC·Filed 2012·Granted Dec 17, 2013·10 cites·1 claims
- 2687US9944752B2Block copolymers for stable micellesINTEZYNE TECH INC·Filed 2016·Granted Apr 17, 2018·2 cites·4 claims
- 2787US8747904B2Polymeric micelles for polynucleotide encapsulationMIROSEVICH JANNI·Filed 2012·Granted Jun 10, 2014·7 cites·22 claims
- 2887US2025129118A1Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2024·Application pending·0 cites
- 2986US12415825B2Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereofBOLD THERAPEUTICS INC·Filed 2023·Granted Sep 16, 2025·0 cites·9 claims
- 3085US8207353B2Poly(ethylene glycol) containing chemically disparate endgroupsSILL KEVIN N·Filed 2010·Granted Jun 26, 2012·3 cites·1 claims
- 3185US8066824B2Covalent modification of metal surfacesBREITENKAMP KURT·Filed 2007·Granted Nov 29, 2011·9 cites·11 claims
- 3284US2023312927A1Poly(sarcosine) polymer excipientsCALUSA BIO LLC·Filed 2023·Application pending·0 cites
- 3381US9944754B2Block copolymers for stable micellesINTEZYNE TECH INC·Filed 2016·Granted Apr 17, 2018·2 cites·8 claims
- 3480US11891482B2Polymer excipients for drug delivery applicationsTYNDALL FORMULATION SERVICES LLC·Filed 2022·Granted Feb 6, 2024·0 cites·18 claims
- 3580US7893277B2Poly(ethylene glycol) containing chemically disparate endgroupsINTEZYNE TECHNOLOGIES INC·Filed 2009·Granted Feb 22, 2011·2 cites·1 claims
- 3679US10143689B2SN-38 loaded iron crosslinked micelle and methods thereofINTEZYNE TECH INC·Filed 2018·Granted Dec 4, 2018·2 cites·16 claims
- 3779US10047197B2Block copolymers for stable micellesINTEZYNE TECH INC·Filed 2016·Granted Aug 14, 2018·2 cites·13 claims
- 3878US12173087B2Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2022·Granted Dec 24, 2024·0 cites·18 claims
- 3977US8524784B2Polymer micelles containing anthracylines for the treatment of cancerSILL KEVIN N·Filed 2010·Granted Sep 3, 2013·1 cites·11 claims
- 4077US8258190B2Encapsulated contrast agentsSKAFF HABIB·Filed 2008·Granted Sep 4, 2012·2 cites·15 claims
- 4174US11230568B2Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Jan 25, 2022·0 cites·18 claims
- 4273US9441013B2Melanocortin 1 receptor ligands and methods of useGILLIES ROBERT J·Filed 2012·Granted Sep 13, 2016·2 cites·16 claims
- 4373US8629186B2Polymer micelles containing anthracyclines for the treatment of cancerINTEZYNE TECHNOLOGIES INC·Filed 2013·Granted Jan 14, 2014·3 cites·10 claims
- 4473US7612153B2Heterobifunctional poly(ethylene glycol) and uses thereofINTEZYNE TECHNOLOGIES INC·Filed 2005·Granted Nov 3, 2009·2 cites·23 claims
- 4569US2010136063A1Immunotherapy for Treatment of Amyloid-Related Disorders Using Encapsulated Beta-Amyloid PeptidesUNIV SOUTH FLORIDA·Filed 2009·Application pending·0 cites
- 4667US10857147B2SN-38 loaded iron crosslinked micelle and methods thereofINTEZYNE TECH INC·Filed 2018·Granted Dec 8, 2020·0 cites·20 claims
- 4764US2009275782A1Quantum Dots Tailored with Electronically-Active PolymersEMRICK TODD S·Filed 2009·Application pending·0 cites
- 4863US2024180844A1Particle compositions comprising polysarcosine lipid conjugatesCALUSA BIO LLC·Filed 2023·Application pending·0 cites
- 4962US11857630B2Formulations of SN-38 with poly(amino acid) block polymersTYNDALL FORMULATION SERVICES LLC·Filed 2021·Granted Jan 2, 2024·0 cites·36 claims
- 5062US2015232616A1Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agentsINTEZYNE TECHNOLOGIES INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 79 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kevin N. Sill files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →